Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, where the product has been classified as an antiseptic under the Household Health Supplies category, permitting immediate importation and marketing. The agreement with local firm PT Pyridam Farma Tbk allows Firebrick to use this approval and commence importation and distribution, subject to local language packaging and finding a marketing partner, positioning the company for growth in Southeast Asia’s largest market.
Under the Product Registration Services Agreement, PT Pyridam Farma will act as Firebrick’s regulatory agent in Indonesia, maintaining approvals and managing interactions with the Ministry of Health in return for reimbursement of regulatory costs and a 4% importation assistance fee. The deal, which runs initially to June 2030 with flexible termination provisions and no minimum sales commitments, offers Firebrick a scalable, low-commitment entry into a market of about 285 million people, potentially marking a key value inflection in its international expansion strategy.
The most recent analyst rating on (AU:FRE) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Firebrick Pharma Limited stock, see the AU:FRE Stock Forecast page.
More about Firebrick Pharma Limited
Firebrick Pharma Limited is an Australian pharmaceutical company focused on developing and commercialising novel formulations and uses of povidone-iodine, particularly in nasal and throat sprays. Its lead product, Nasodine Nasal Spray, along with Nasodine Throat Spray, has been introduced in markets including the United States, Singapore, Fiji and the broader South Pacific, with expansion plans targeting up to 10 countries over three years.
Average Trading Volume: 62,074
Technical Sentiment Signal: Sell
Current Market Cap: A$13.63M
Learn more about FRE stock on TipRanks’ Stock Analysis page.